These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1490494)

  • 1. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome.
    Timmings PL; Richens A
    Eur Neurol; 1992; 32(6):305-7. PubMed ID: 1490494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years.
    Buchanan N
    Seizure; 1996 Sep; 5(3):209-14. PubMed ID: 8902923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine: clinical experience in 93 patients with epilepsy.
    Buchanan N
    Acta Neurol Scand; 1995 Jul; 92(1):28-32. PubMed ID: 7572057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Marson AG; Baker GA
    Cochrane Database Syst Rev; 2000; (3):CD001909. PubMed ID: 10908514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Marson AG; Baker GA
    Cochrane Database Syst Rev; 2001; (3):CD001909. PubMed ID: 11687001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine therapy of epilepsy in tuberous sclerosis.
    Franz DN; Tudor C; Leonard J; Egelhoff JC; Byars A; Valerius K; Sethuraman G
    Epilepsia; 2001 Jul; 42(7):935-40. PubMed ID: 11488895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG.
    Bisulli F; Baruzzi A; Rosati A; Riva R; Avoni P; Cerullo A; Tinuper P
    Epileptic Disord; 2001 Sep; 3(3):151-6. PubMed ID: 11679308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes.
    Dulac O; Kaminska A
    J Child Neurol; 1997 Nov; 12 Suppl 1():S23-28. PubMed ID: 9429127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimizing epilepsy therapy in children and adolescents with lamotrigine].
    Siemes H; Brandl U; Helmstädter C; Kurlemann G; Rating D; Sälke-Kellermann RA; Stephani U; Uberall M; Wiemer-Kruel A; Bergmann L
    Klin Padiatr; 2005; 217(4):222-9. PubMed ID: 16032548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old.
    Piña-Garza JE; Elterman RD; Ayala R; Corral M; Mikati MA; Piña-Garza MJ; Warnock CR; Conklin HS; Messenheimer JA
    J Child Neurol; 2008 Aug; 23(8):853-61. PubMed ID: 18660469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized purpura associated with lamotrigine.
    Amlie-Lefond CM; Felgenhauer JL; Leong AD
    Pediatr Neurol; 2006 Sep; 35(3):227-8. PubMed ID: 16939867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
    N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoclonic status epilepticus following high-dosage lamotrigine therapy.
    Guerrini R; Belmonte A; Parmeggiani L; Perucca E
    Brain Dev; 1999 Sep; 21(6):420-4. PubMed ID: 10487478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.